Влияние антипсихотических препаратов на обмен веществ

Полный текст:

Список литературы

1. Gury C. Schizophrenia, diabetes mellitus and antipsychotics. Encephale. 2004 Jul-Aug;30(4):382–91.

2. Weiden P, Mackell J, McDonnell D. Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Res. 2004;66:51–57.

3. Fiedorowicz J, Miller D, Jeffrey R, Chadi A, Ellingrod L, William G. Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers. Curr Psychiatry Rev. 2012;8(1):25–36.

4. Newcomer J. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19 (Suppl 1):1–93.

5. Baptista T, Lacruz A, Meza T, Contreras Q, Delgado C, Mejias M, Hernаndez L. Antipsychotic Drugs and Obesity: Is Prolactin Involved? Can J Psychiatry. 2001;46:829–834.

6. Melkersson K, Berinder K, Hulting A. Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses. Neuro Endocrinol Lett. 2011;32(4):428–36.

7. Lieberman J. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. New England Journal of Medicine. 2005;353:1209–23.

8. Haupt D, Newcomer J. Hyperglycemia and antipsychotic medications. J Clin Psychiatry. 2001;62 Suppl 27:15–26; discussion 40–1.

Для цитирования:

Unilinen O.A., Starostina E.G. Влияние антипсихотических препаратов на обмен веществ. Ожирение и метаболизм. 2012;9(3):11-13.

For citation:

., . Metabolic effects of antipsychotic drugs. Obesity and metabolism. 2012;9(3):11-13. (In Russ.)

Просмотров: 16

Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.

ISSN 2071-8713 (Print)
ISSN 2306-5524 (Online)